相关实验视频

Updated: May 11, 2025

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

树突细胞衍生外细胞囊泡被设计为在它们的表面表达介质蛋白-12和抗CTLA-4,用于组合癌症免疫疗法

Jiangbin Chen^1,2,3, Qi Tan^1,2,3, Zimo Yang^1,2,3

¹Department of Respiratory and Critical Care Medicine, Hubei Province Clinical Research Center for Major Respiratory Diseases, and NHC Key Laboratory of Pulmonary Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

Journal of extracellular vesicles

|April 16, 2025

概括

由树突细胞衍生的外细胞囊泡 (DEVs) 与IL-12和抗CTLA-4 (aCTLA-4) 相结合,增强T细胞激活,改善癌症免疫疗法.

科学领域:

免疫学免疫学免疫学
生物技术是生物技术.
癌症研究癌症研究

背景情况:

树突细胞 (DC) 衍生的细胞外囊泡 (DEVs) 显示出作为癌症疫苗的潜力,但需要优化.
免疫检查点抑制剂和细胞因子对于有效的抗癌T细胞反应至关重要.

研究的目的:

用IL-12和aCTLA-4设计DEV,以增强其抗癌免疫疗法潜力.
研究DEVs,IL-12和aCTLA-4对T细胞激活和瘤抑制的联合作用.

主要方法:

使用新抗原,LPS和IFN-γ的DC成熟,随后进行DEV隔离.
DEVs与IL-12和aCTLA-4 (DEV@IL-12-aCTLA-4) 的结合.
在小鼠瘤模型中对DEV@IL-12-aCTLA-4进行免疫反应和瘤生长抑制的评估.

主要成果:

DEV@IL-12-aCTLA-4通过提供免疫调节信号并促进向传递,增强了T细胞激活.
工程DEVs促进了Th1免疫反应,并在瘤微环境中逆转了耗尽的CD8+T细胞.
在携带瘤的小鼠中,DEV@IL-12-aCTLA-4有效抑制了瘤的生长.

结论:

DEV@IL-12-aCTLA-4是一种补充策略,增强T细胞激活并提供治疗有效载荷.
重编程DEV为优化组合癌症免疫疗法提供了一种通用方法.

更多相关视频

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...